These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3156024)

  • 21. Penetration of ciprofloxacin into prostatic fluid, ejaculate and seminal fluid in volunteers after an oral dose of 750 mg.
    Naber KG; Sörgel F; Kinzig M; Weigel DM
    J Urol; 1993 Nov; 150(5 Pt 2):1718-21. PubMed ID: 8411457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ciprofloxacin concentrations in human fluids and tissues following a single oral dose.
    Esposito S; Galante D; Barba D; D'Errico G; Mazzone A; Montanaro S
    Int J Clin Pharmacol Res; 1987; 7(3):181-6. PubMed ID: 3596861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of ciprofloxacin in healthy volunteers after oral and intravenous administration.
    Borner K; Höffken G; Lode H; Koeppe P; Prinzing C; Glatzel P; Wiley R; Olschewski P; Sievers B; Reinitz D
    Eur J Clin Microbiol; 1986 Apr; 5(2):179-86. PubMed ID: 2941277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and tissue penetration of ciprofloxacin.
    Crump B; Wise R; Dent J
    Antimicrob Agents Chemother; 1983 Nov; 24(5):784-6. PubMed ID: 6660852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of intravenously administered ciprofloxacin.
    Wise R; Lockley RM; Webberly M; Dent J
    Antimicrob Agents Chemother; 1984 Aug; 26(2):208-10. PubMed ID: 6486762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pharmacokinetics of ciprofloxacin in patients with impaired renal function.
    Boelaert J; Valcke Y; Schurgers M; Daneels R; Rosseneu M; Rosseel MT; Bogaert MG
    J Antimicrob Chemother; 1985 Jul; 16(1):87-93. PubMed ID: 2931415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tissue penetration of ciprofloxacin after single and multiple doses.
    LeBel M; Vallée F; Bergeron MG
    Antimicrob Agents Chemother; 1986 Mar; 29(3):501-5. PubMed ID: 2940974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and tolerance of ciprofloxacin after sequential increasing oral doses.
    Tartaglione TA; Raffalovich AC; Poynor WJ; Espinel-Ingroff A; Kerkering TM
    Antimicrob Agents Chemother; 1986 Jan; 29(1):62-6. PubMed ID: 2942101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of intravenously administered ciprofloxacin in intensive care patients with acute renal failure.
    Dirksen MS; Vree TB
    Pharm Weekbl Sci; 1986 Feb; 8(1):35-9. PubMed ID: 2938069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum and prostatic tissue concentrations of moxifloxacin in patients undergoing transurethral resection of the prostate.
    Wagenlehner FM; Lunz JC; Kees F; Wieland W; Naber KG
    J Chemother; 2006 Oct; 18(5):485-9. PubMed ID: 17127224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intraperitoneal penetration of ciprofloxacin.
    Lockley MR; Waldron R; Wise R; Donovan IA
    Eur J Clin Microbiol; 1986 Apr; 5(2):209-10. PubMed ID: 2941284
    [No Abstract]   [Full Text] [Related]  

  • 32. [Ciprofloxacine: evaluation of its biliary elimination in man].
    Brogard JM; Jehl F; Arnaud JP; Lévy P; Peladan F; Blicklé JF; Monteil H
    Schweiz Med Wochenschr; 1985 Mar; 115(13):448-53. PubMed ID: 3158073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of high-pressure liquid chromatography and microbiological assay for the determination of biliary elimination of ciprofloxacin in humans.
    Brogard JM; Jehl F; Monteil H; Adloff M; Blickle JF; Levy P
    Antimicrob Agents Chemother; 1985 Aug; 28(2):311-4. PubMed ID: 2939796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aqueous humor and plasma concentrations of ciprofloxacin and moxifloxacin following topical ocular administration in ophthalmologically normal horses.
    Clode AB; Davis JL; Salmon J; LaFevers H; Gilger BC
    Am J Vet Res; 2010 May; 71(5):564-9. PubMed ID: 20433383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Penetration of ciprofloxacin into gynecologic tissues.
    Dalhoff A; Weuta H
    Am J Med; 1987 Apr; 82(4A):133-8. PubMed ID: 3555027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of ciprofloxacin. 2nd communication: distribution to and elimination from tissues and organs following single or repeated administration of [14C]ciprofloxacin in albino rats.
    Siefert HM; Maruhn D; Scholl H
    Arzneimittelforschung; 1986 Oct; 36(10):1503-10. PubMed ID: 3101707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Penetration of fleroxacin into prostatic secretion and prostatic adenoma tissue.
    Kees F; Naber KG; Schumacher H; Grobecker H
    Chemotherapy; 1988; 34(6):437-43. PubMed ID: 2468456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prostatic tissue and fluid levels of lomefloxacin (NY-198)].
    Nasu Y; Nishitani Y; Yamada D; Hayata S; Tsugawa M; Kishi M; Mizuno A; Kumon H; Ohmori H; Nanba K
    Hinyokika Kiyo; 1989 Mar; 35(3):551-6. PubMed ID: 2735259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Penetration of ciprofloxacin into kidney, fat, muscle and skin tissue.
    Daschner FD; Westenfelder M; Dalhoff A
    Eur J Clin Microbiol; 1986 Apr; 5(2):212-3. PubMed ID: 2941285
    [No Abstract]   [Full Text] [Related]  

  • 40. Multiple-dose pharmacokinetics and safety of ciprofloxacin in normal volunteers.
    Gonzalez MA; Uribe F; Moisen SD; Fuster AP; Selen A; Welling PG; Painter B
    Antimicrob Agents Chemother; 1984 Nov; 26(5):741-4. PubMed ID: 6517556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.